Trial

A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

Study Director
Start Date
11 / 2015
Trial Phase
Phase I
Trial Status
early termination
Current Enrollment
Target Enrollment
18
Overview
Terminated A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
Phase: Phase 1
Number Enrolled: 18
NCT Number: NCT02606214
Other IDs: TBA-354-CL-002
Study Start: November 2015
Primary Completion: December 2015
Study Completion:  
Last Verified: April 2016
Related Links
TBA354 discontinued
Compound Associations
TBA-354